Abstract
Tocotrienols, components belonging to vitamin E members, are used as potent therapeutics in the treatment of several diseases. Recent studies suggested tocotrienol to have better activity in many situations compared to tocopherols. Tocotrienols have been shown to lower the atherogenic apolipoprotein B and lipoprotein plasma levels. Additionally, tocotrienols with their anti-tumor effect together with anti-angiogenic and anti-thrombotic effects may serve as effective agents in cancer therapy. Besides these effects, some properties such as water insolubility and low stability limit the usage of tocotrienols in the clinic. However recent studies tried to increase the bioavailability with esterification and combination use. These efforts for the clinical usage of tocotrienols which may help them to take a wide place in the clinic and additional studies are needed to identify their therapeutical mechanisms.
Keywords: Tocotrienols, atherosclerosis, Alzheimer's disease, cancer, therapy, chromanoxyl radicals, superoxide dismutase, hypercholesterolemia, neoplasms, Melanin
Current Pharmaceutical Design
Title: Cellular Protection and Therapeutic Potential of Tocotrienols
Volume: 17 Issue: 21
Author(s): Betul Catalgol, Saime Batirel and Nesrin Kartal Ozer
Affiliation:
Keywords: Tocotrienols, atherosclerosis, Alzheimer's disease, cancer, therapy, chromanoxyl radicals, superoxide dismutase, hypercholesterolemia, neoplasms, Melanin
Abstract: Tocotrienols, components belonging to vitamin E members, are used as potent therapeutics in the treatment of several diseases. Recent studies suggested tocotrienol to have better activity in many situations compared to tocopherols. Tocotrienols have been shown to lower the atherogenic apolipoprotein B and lipoprotein plasma levels. Additionally, tocotrienols with their anti-tumor effect together with anti-angiogenic and anti-thrombotic effects may serve as effective agents in cancer therapy. Besides these effects, some properties such as water insolubility and low stability limit the usage of tocotrienols in the clinic. However recent studies tried to increase the bioavailability with esterification and combination use. These efforts for the clinical usage of tocotrienols which may help them to take a wide place in the clinic and additional studies are needed to identify their therapeutical mechanisms.
Export Options
About this article
Cite this article as:
Catalgol Betul, Batirel Saime and Ozer Nesrin Kartal, Cellular Protection and Therapeutic Potential of Tocotrienols, Current Pharmaceutical Design 2011; 17 (21) . https://dx.doi.org/10.2174/138161211796957436
DOI https://dx.doi.org/10.2174/138161211796957436 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: GPCR-Targeted Drug Development)
Current Drug Targets Vascular Endothelium: Functioning in Norm, Changes in Atherosclerosis and Current Dietary Approaches to Improve Endothelial Function
Mini-Reviews in Medicinal Chemistry Multifunctional Nanoparticles, Nanocages and Degradable Polymers as a Potential Novel Generation of Non-Invasive Molecular and Cellular Imaging Systems
Recent Patents on Nanotechnology Cell-Based Therapy to Promote Angiogenesis in the Brain Following Ischemic Damage
Current Vascular Pharmacology Long-Term Use of Short- and Long-Acting Nitrates in Stable Angina Pectoris
Current Clinical Pharmacology Macrophages: Promising Targets for the Treatment of Atherosclerosis
Current Vascular Pharmacology Mononuclear Cell Recruitment and Inflammation in Atherosclerosis
Vascular Disease Prevention (Discontinued) The Role of the Endothelium in Premature Atherosclerosis: Molecular Mechanisms
Current Medicinal Chemistry The Role of Combined Assessment of Defense Against Oxidative Stress and Inflammation in the Evaluation of Peripheral Arterial Disease
Current Molecular Medicine Pregnancy in Type 2 Diabetes Mellitus - Problems & Promises
Current Diabetes Reviews Commentary : Hypothesis Focused Ultrasound and NXY-059 in Experimental Cerebral Ischemia: A New Therapeutic Opportunity?
CNS & Neurological Disorders - Drug Targets Drug-Delivery Systems of Green Tea Catechins for Improved Stability and Bioavailability
Current Medicinal Chemistry Dietary Factors Influencing Magnesium Absorption in Humans
Current Nutrition & Food Science Outline of Proteins and Signaling Pathways Involved in Heart Failure
Current Protein & Peptide Science Targeted Drug Delivery for Cardiovascular and Cerebrovascular Diseases
Current Drug Targets Novel Therapies for Schizophrenia: Understanding the Glutamatergic Synapse and Potential Targets for Altering N-methyl-D-aspartate Neurotransmission
Recent Patents on CNS Drug Discovery (Discontinued) Causes of Impaired Fertility in Women with Polycystic Ovary Syndrome
Current Women`s Health Reviews Vitamin D and Vitamin D Receptor Activators in Treatment of Hypertension and Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Functional Polymeric Nano/Microparticles for Surface Adsorption and Delivery of Protein and DNA Vaccines
Current Drug Delivery Neurotrophic and Neuroprotective Effects of Muscle Contraction
Current Pharmaceutical Design